North America Amniotic Membrane Market to Grow at a CAGR of 7.5% to reach US$ 1175.2 Million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Amniotic Membrane Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Amniotic Membrane Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Prevalence of Chronic Wounds
5.1.2 Higher awareness and adoption of regenerative medicine
5.1.3 Advancements in Processing Techniques

5.2 Market Opportunities

5.2.1 Expanding Applications in Ophthalmology
5.2.2 Increased Use in Surgical Procedures
5.2.3 Collaboration with Biotechnology Firms

5.3 Future Trends

5.3.1 Growth in Tissue Engineering
5.3.2 Development of Combination Products
5.3.3 Regulation Approval

5.4 Impact of Drivers and Restraints

6. North America Amniotic Membrane Market Regional Analysis

6.1 North America Amniotic Membrane Market Overview

6.2 North America Amniotic Membrane Market Revenue 2017-2027 (US$ Million)

6.3 North America Amniotic Membrane Market Forecast Analysis

7. North America Amniotic Membrane Market Analysis – by Enzyme

7.1 Cryopreserved Amniotic Membrane

7.1.1 Overview
7.1.2 Cryopreserved Amniotic Membrane: North America Amniotic Membrane Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Dehydrated Amniotic Membrane

7.2.1 Overview
7.2.2 Dehydrated Amniotic Membrane: North America Amniotic Membrane Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Amniotic Membrane Market Analysis – by Application

8.1 Surgical Wounds

8.1.1 Overview
8.1.2 Surgical Wounds: North America Amniotic Membrane Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Ophthalmology

8.2.1 Overview
8.2.2 Ophthalmology: North America Amniotic Membrane Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Amniotic Membrane Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Ophthalmology: North America Amniotic Membrane Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Ambulatory Surgical Centers

9.2.1 Overview
9.2.2 Ophthalmology: North America Amniotic Membrane Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Specialty Clinics

9.3.1 Overview
9.3.2 Ophthalmology: North America Amniotic Membrane Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Research Institute

9.4.1 Overview
9.4.2 Ophthalmology: North America Amniotic Membrane Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Academic Institutes

9.5.1 Overview
9.5.2 Ophthalmology: North America Amniotic Membrane Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Amniotic Membrane Market – North America Analysis

10.1 North America

10.1.1 North America Amniotic Membrane Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 North America Amniotic Membrane Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Amniotic Membrane Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 US: North America Amniotic Membrane Market Breakdown, by Enzyme
10.1.1.1.2 US: North America Amniotic Membrane Market Breakdown, by Application
10.1.1.1.3 US: North America Amniotic Membrane Market Breakdown, by End User

10.1.1.2 Canada: North America Amniotic Membrane Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Canada: North America Amniotic Membrane Market Breakdown, by Enzyme
10.1.1.2.2 Canada: North America Amniotic Membrane Market Breakdown, by Application
10.1.1.2.3 Canada: North America Amniotic Membrane Market Breakdown, by End User

10.1.1.3 Mexico : North America Amniotic Membrane Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Mexico : North America Amniotic Membrane Market Breakdown, by Enzyme
10.1.1.3.2 Mexico : North America Amniotic Membrane Market Breakdown, by Application
10.1.1.3.3 Mexico : North America Amniotic Membrane Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Amniotic Membrane Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Surgenex, LLC

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Amnio Technology, LLC

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Katena Products. Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Amniox Medical, Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Smith & Nephew

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Organogenesis Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 MiMedx

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Skye Biologics Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Integra Life Sciences Corporation

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Applied Biologics LLC

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights